Presentation

30-Day Outcomes From an Early Feasibility Study to Assess the Safety and Effectiveness of a Novel Transfemoral TAVR System for the Treatment of Patients With Symptomatic Severe Aortic Regurgitation (AR)

Presenter: Vinod Thourani

June 13, 2019

REGISTER for free or LOG IN to view this content

30-Day Outcomes From an Early Feasibility Study to Assess the Safety and Effectiveness of a Novel Transfemoral TAVR System for the Treatment of Patients With Symptomatic Severe Aortic Regurgitation (AR)

Structural Heart

Presentation

TVT 2019

Aortic Valve

Up Next

Presentation

Initial Experience With the JenaValve Transfemoral TAVR System in Patients With Severe Aortic Stenosis and Risk for Coronary Occlusion

Presenter: Torsten Vahl

June 13, 2019

More slides +

Presentation

Secondary Curve on TAVR Delivery Wire Effects on Outcomes in Patients With Severe Aortic Root Angles

Presenter: Philip Carson

June 13, 2019

Presentation

OPTIMUM TAV First-In-Human Results

Presenter: Mathew Williams

June 13, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.